Literature DB >> 20860103

Plasma and tissue cage fluid pharmacokinetics of marbofloxacin after intravenous, intramuscular, and oral single-dose application in pigs.

H Ding1, Y Li, Z Chen, M Rizwan-ul-Haq, Z Zeng.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20860103     DOI： 10.1111/j.1365-2885.2010.01164.x

Source DB:  PubMed          Journal:  J Vet Pharmacol Ther        ISSN： 0140-7783            Impact factor:   1.786


× No keyword cloud information.
  11 in total

1.  Using In Vitro Dynamic Models To Evaluate Fluoroquinolone Activity against Emergence of Resistant Salmonella enterica Serovar Typhimurium.

Authors:  Seung-Jin Lee; Elias Gebru Awji; Na-Hye Park; Seung-Chun Park
Journal:  Antimicrob Agents Chemother       Date:  2017-01-24       Impact factor: 5.191

2.  Response of a clinical Escherichia coli strain to repeated cefquinome exposure in a piglet tissue-cage model.

Authors:  Mengxiao Gu; Nan Zhang; Longfei Zhang; Mingpeng Xiong; Yuanyuan Yang; Xiaoyan Gu; Xiangguang Shen; Huanzhong Ding
Journal:  BMC Vet Res       Date:  2015-07-25       Impact factor: 2.741

3.  PK-PD Analysis of Marbofloxacin against Streptococcus suis in Pigs.

Authors:  Zhixin Lei; Qianying Liu; Bing Yang; Haseeb Khaliq; Jiyue Cao; Qigai He
Journal:  Front Pharmacol       Date:  2017-11-20       Impact factor: 5.810

4.  Pharmacokinetic and Pharmacodynamic Evaluation of Marbofloxacin and PK/PD Modeling against Escherichia coli in Pigs.

Authors:  Zhixin Lei; Qianying Liu; Jincheng Xiong; Bing Yang; Shuaike Yang; Qianqian Zhu; Kun Li; Shishuo Zhang; Jiyue Cao; Qigai He
Journal:  Front Pharmacol       Date:  2017-08-21       Impact factor: 5.810

5.  Integrated pharmacokinetic-Pharmacodynamic (PK/PD) model to evaluate the in vivo antimicrobial activity of Marbofloxacin against Pasteurella multocida in piglets.

Authors:  Qing Lin Zeng; Xian Mei; Jia Su; Xiao Hong Li; Wen Guang Xiong; Yan Lu; Zhen Ling Zeng
Journal:  BMC Vet Res       Date:  2017-06-15       Impact factor: 2.741

6.  Prediction of marbofloxacin dosage for the pig pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida by pharmacokinetic/pharmacodynamic modelling.

Authors:  Lucy Dorey; Ludovic Pelligand; Peter Lees
Journal:  BMC Vet Res       Date:  2017-07-01       Impact factor: 2.741

7.  Pharmacokinetic and Pharmacodynamic Evaluation of Marbofloxacin in Pig against Korean Local Isolates of Actinobacillus pleuropneumoniae.

Authors:  Md Akil Hossain; Hae-Chul Park; Kyunghun Jeong; Yang Ho Jang; Dae Gyun Kim; JeongWoo Kang; Kwang-Jick Lee
Journal:  Biomed Res Int       Date:  2017-04-06       Impact factor: 3.411

8.  Pharmacokinetics of marbofloxacin in pigs after intravenous and intramuscular administration of a single dose of 8 mg/kg: dose proportionality, influence of the age of the animals and urinary elimination.

Authors:  M Schneider; A Paulin; F Dron; F Woehrlé
Journal:  J Vet Pharmacol Ther       Date:  2014-03-25       Impact factor: 1.786

9.  Tissue distribution of marbofloxacin in pigs after a single intramuscular injection.

Authors:  Fan Yang; Yiming Liu; Zhili Li; Yuqin Wang; Baobao Liu; Zhensheng Zhao; Bianhua Zhou; Guoyong Wang
Journal:  J Vet Sci       Date:  2017-06-30       Impact factor: 1.672

10.  Evaluation of Marbofloxacin in Beagle Dogs After Oral Dosing: Preclinical Safety Evaluation and Comparative Pharmacokinetics of Two Different Tablets.

Authors:  Zhixin Lei; Qianying Liu; Bing Yang; Haseeb Khaliq; Saeed Ahmed; Bowen Fan; Jiyue Cao; Qigai He
Journal:  Front Pharmacol       Date:  2018-04-10       Impact factor: 5.810
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.